Response and durability of anti-PD-(L) 1 therapy in never- or light-smokers with non-small cell lung cancer (NSCLC) and high PD-L1 expression Meeting Abstract

  


Authors: Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Mooradian, M.; Lydon, C. A.; Anderson, D.; Tenet, M.; Sauter, J. L.; Mino-Kenudson, M.; Shaw, A. T.; Awad, M. M.; Hellmann, M. D.
Abstract Title: Response and durability of anti-PD-(L) 1 therapy in never- or light-smokers with non-small cell lung cancer (NSCLC) and high PD-L1 expression
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 462s
Language: English
ACCESSION: WOS:000442916003185
DOI: 10.1200/JCO.2018.36.15_suppl.9011
PROVIDER: wos
Notes: Meeting Abstract: 9011 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann
  2. Hira Abbas Rizvi
    122 Rizvi
  3. Jennifer Lynn Sauter
    124 Sauter
  4. Megan Alexandra Tenet
    8 Tenet
Related MSK Work